Vorinostat and sorafenib synergistically kill tumor cells via FLIP suppression and CD95 activation

類似資料

• Sorafenib and Vorinostat Kill Colon Cancer Cells by CD95-Dependent and -Independent Mechanisms
  著者:: Walker, Teneille, 等
  出版事項: (2009)
• Vorinostat and sorafenib increase ER stress, autophagy and apoptosis via ceramide-dependent CD95 and PERK activation
  著者:: Park, Margaret A., 等
  出版事項: (2008)
• MEK1/2 inhibitors and 17AAG synergize to kill human GI tumor cells in vitro via suppression of c-FLIP-s levels and activation of CD95
  著者:: Park, Margaret A., 等
  出版事項: (2008)
• MDA-7/IL-24–induced cell killing in malignant renal carcinoma cells occurs by a ceramide/CD95/PERK–dependent mechanism
  著者:: Park, Margaret A., 等
  出版事項: (2009)
• Sorafenib and HDAC inhibitors synergize to kill CNS tumor cells
  著者:: Tang, Yong, 等
  出版事項: (2012)